Skip to main content



Colonel (Ret.) Craig Shriver, MD

Colonel (Ret.) Craig Shriver, MD

Director, Murtha Cancer Center, Walter Reed National Military Medical Center

COL (Ret) Shriver is the Oliver H. Beahrs Professor of Surgery at the Uniformed Services University of the Health Sciences (USUHS), and the Director of the Murtha Cancer Center / Research Program (MCC / MCCRP) at the USUHS and Walter Reed National Military Medical Center (WRNMMC) in Bethesda. He is also Director of the congressionally-mandated Clinical Breast Cancer Project (CBCP), a military-civilian coalition providing excellent clinical care, cutting-edge breast cancer research, and an extensive biorepository of human breast cancers and tissue that are used by researchers around the world. 

COL (Ret) Shriver earned a Bachelor's Degree in Biochemistry (Cum Laude) from the Albright College in Reading, Pennsylvania and an MD (Alpha Omega Alpha) from Temple University School of Medicine. COL (Ret) Shriver was commissioned into the U.S. Army Medical Corps in 1984. His postgraduate training included his surgical internship and residency at the Walter Reed Army Medical Center. Dr. Shriver was selected for advanced fellowship training in surgical oncology at the Memorial Sloan-Kettering Cancer Center in New York which he completed in 1993. 

COL (Ret) Shriver’s military education includes completion of the Advanced Officer Course, and graduating with honors (top 10% of his class) from the Command and General Staff College in June 2000. His operational assignments included a 2-year tour at Fort Liberty, North Carolina, and direct surgical support of four overseas combat military operations (deployments). He deployed in support of Operation Just Cause (the liberation of Panama) in 1989, serving as Chief Triage Officer and Surgeon for the Forward Surgical Team of the 5th MASH. He then went on to become Surgeon of the 307th Medical Battalion of the 82nd Airborne Division, providing far-forward surgical support during Operation Desert Shield and Desert Storm (1990–1991), and earning the coveted Combat Medical Badge. He was decorated by his command for his direct surgical support of the medical response to the terrorist attack against the Pentagon on 11 September 2001. In 2007, COL (Ret) Shriver served in eastern Afghanistan with the 1-91 Cavalry, 173rd Airborne, winning the coveted “Order of the Spur” award from his cavalry unit for gallant and intrepid service under fire on the front lines of combat in Afghanistan. COL (Ret) Shriver also was decorated with the Combat Action Badge during that tour, for service under fire in direct engagement with enemy forces. COL (Ret) Shriver completed his fourth combat tour, second in Afghanistan and this time in Herat in Western Afghanistan, returning on 20 February 2011.

Other military awards include the Legion of Merit (1OLC), Meritorious Service Medal, Joint Services Commendation Medal, Army Commendation Medal (2OLC), and the Civilian Outstanding Service Medal. He was awarded the prestigious “A” Designator Award from the Surgeon General, given to only a select few military physicians who are the leaders of healthcare in the Army. He was awarded the Order of Military Medical Merit, given to “civilian or military physicians who meet the highest standard of “citizen-soldier-physician.” In 2008, COL (Ret) Shriver was promoted to the rank of Professor of Surgery at the USUHS in Bethesda, Maryland. COL (Ret) Shriver in 2010 was elected into the prestigious American Surgical Association, the oldest and most premier of all surgical societies in the world. COL (Ret) Shriver has been an author on three separate articles published in the prestigious New England Journal of Medicine, and has also been an author on an article in the world’s most premier research publication, Nature, in October 2012. A nationally-known Surgical Oncologist and as Director of the MCC, COL (Ret) Shriver in July 2014 served on a U.S. Food and Drug Administration (FDA) Panel as an Advisor to the FDA, evaluating the controversial surgical technique known as laparoscopic power morcellation. COL (Ret) Shriver was selected by USUHS as the first Oliver H. Beahrs Professor of Surgery in April 2015. COL (Ret) Shriver was chosen by DoD Health Affairs to lead the DoD efforts of the federal Cancer Moonshot in 2016 and again in 2022 which have resulted in the research programs of APOLLO (Applied Proteogenomic Organizational Learning and Outcomes), DoD Framingham, and PROMETHEUS (PROject for Military Exposure and Toxin History Evaluation in US service members). He went on to retire from active duty in June 2018, after 34 years of active military service. Dr. Shriver now works at the Uniformed Services University of the Health Sciences with a primary focus on educating our future military medical leaders and running the DoD’s largest and best-funded cancer research program; he also maintains a clinical cancer surgery practice at Walter Reed National Military Medical Center, Bethesda, Maryland. Dr. Shriver was elected into the prestigious Southern Surgical Association in December 2018. Dr. Shriver also serves through the Defense Health Agency as the Secretary of Defense’s ex-officio representative to the National Cancer Advisory Board (NCAB), the board that oversees the National Cancer Institute of the NIH.


  • We are extremely excited to convene the community at SOF Week 2024. This convention for U.S. and International SOF will include a diverse slate of programs, to include professional development sessions, interactive discussions about the future of SOF, and an up-close view of some of the best tech available to our warfighters. GSOF looks forward to working with USSOCOM to make SOF Week 2024 an impactful event.
    Stuart Bradin
    President and CEO, GSOF


Co-sponsorship of this event does not imply endorsement of GSOF, its services, or products by the United States Government, the Department of Defense, or U.S. Special Operations Command.